More reading. The following text excerpt is from the official website…

Peripheral Neuropathy

Peripheral Neuropathy occurs most frequently in people who smoke, are over age 40, and have difficulty controlling their blood sugar levels. In fact, about half of all people with diabetes and thousands of others who suffer from immune system disorders, infection, trauma, or alcoholism are expected to develop Peripheral Neuropathy.

Fortunately, Peripheral Neuropathy can be prevented or its progression slowed. By recognizing the early signs and symptoms, you can get prompt diagnosis and treatment.

You have come to the right place to learn about Peripheral Neuropathy. Here you will gain knowledge about what causes Peripheral Neuropathy and the various treatment options including nerve blocks, surgery, and the newest drugs used to manage Peripheral Neuropathy.

You will learn about the latest clinical advances in the management of Peripheral Neuropathy as well as about the treatment options that are available. You will also learn about the doctors, hospitals, and medical centers that are at the leading edge in conducting clinical research about Peripheral Neuropathy.

Information on ongoing clinical trials, a list of questions to ask your doctor, and a useful directory of resources and organizations that can help patients with Peripheral Neuropathy complete this report.

Learn more by ordering your MediFocus Guidebook on Peripheral Neuropathy, the most comprehensive, up-to-date source of information available. You will get answers to your questions, including:

  • What are the risk factors of Peripheral Neuropathy?
  • What standard and alternative treatment options are available?
  • Where are the leading doctors, hospitals and medical centers that specialize in Peripheral Neuropathy research and treatment?
  • What are the results of the latest clinical trials?
  • Where are the support groups and additional resources in my area?
  • What are the promising new treatments on the horizon?

Read more about Peripheral Neuropathy on the Medifocus website…

By |2017-12-11T10:04:30+11:00November 29th, 2011|Help, Learn, Professional Resources|5 Comments


  1. Moushmi April 28, 2012 at 11:46 am - Reply

    Disappointing is that from such a severe injury which damages peoples health and life the only observation was a book. Some people are lucky enough to simply walk away from things they do not like and continue with the things they love. People like Soula can not just walk away from this condition and continue what it is they love instead they not only walk WITH it but wear and face it everyday every hour. A comment like that just pollutes such a brilliant site which was unfortunately built throught a persons terrific injury. So kindly walk away next time you don’t like something and let those who can and do appreciate such information .

  2. elaine marshall April 25, 2012 at 12:56 pm - Reply

    Disappointed when I followed the link to this website to find it was all about buying a book!

    • wcvictim April 25, 2012 at 3:49 pm - Reply

      Elaine, looks like you may need glasses or a course in reading… This website is a fantastic source for people, like, Soula, who suffer from genuine neuropathic pain. I am a severely injured worker and I suffer from severe nociceptive as well neuropathic pain following a physical assault. I come here, on this site, to learn about all things pain, in particular advances in pain management and I find this site of tremendous value.
      I can’t believe you are so apathetic as to leave such a demeaning comment on such a valuable and resourceful website.

    • soula April 26, 2012 at 10:30 am - Reply

      Wow, I must admit I am almost speechless at this comment. Are you disappointed with any of the other free material that was compiled over months by us, without funding or support or even one ad to interrupt you while you used the site? Move on love, if you’re disappointed then don’t use the site.

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.